Previous Investor Exclusives:

An Update On American Superconductor Stock (AMSC) – by Damon Judd (September 22, 2025)

Back To The Well On FEMSA (FMX)? – by Jeffrey Fischer, CFA (September 9, 2025)

Is Biopharma Precigen (PGEN) Still Buyable After Near-Tripler? – by Sean Daly (August 27, 2025)

Cash-In Or Hold Onto Post-Merger Steelcase (SCS)? – by Daniel Shvartsman (August 12, 2025)

Dentalcorp (DNTL.CA) Undervalued: Solid OCF, CDCP Tailwind – by Jeffrey Fischer, CFA (August 4, 2025)

Joby Has Tailwinds Beyond Recent Gains – by Ahmed Abdelazim, CFA (July 23, 2025)

Reassessing Tripadvisor (TRIP) Amid Starboard’s Filing – by Daniel Shvartsman (July 18, 2025)

Reassessing MIND Technology After 60%+ Gain In Just 10 Weeks – by Sean Daly (July 6, 2025)

Carnival Corp (CCL) Still Deserves More – by Felipe Brum, CFA (July 1, 2025)

Telus International/Digital (TIXT) Merger Premium Looks Suspect – SELL – by Jeffrey Fischer, CFA (June 29, 2025)

Platinum: Patience, Prosperity & Further Potential, After 30% 1-Month Gain – by Jeffrey Fischer, CFA (June 11, 2025)

Quipt Home Medical (QIPT) Could Go Either Way Amid Intriguing Activist Involvement, Recent 50% One-Day Jump – by Thomas Niel (May 26, 2025)

Time To Cash In On Quick 50% Gains From GAP – by Jeffrey Fischer, CFA (May 22, 2025)

Assessing Array Technology’s (ARRY) 70% Jump Following Earnings, Budget News – by Paul Franke (May 14, 2025)

How To Approach D-Wave Quantum (QBTS) After 500% Gain – by Stephen Tobin (May 6, 2025)